28392767|t|Early-Onset Network Hyperexcitability in Presymptomatic Alzheimer's Disease Transgenic Mice Is Suppressed by Passive Immunization with Anti-Human APP/Abeta Antibody and by mGluR5 Blockade.
28392767|a|Cortical and hippocampal network hyperexcitability appears to be an early event in Alzheimer's disease (AD) pathogenesis, and may contribute to memory impairment. It remains unclear if network hyperexcitability precedes memory impairment in mouse models of AD and what are the underlying cellular mechanisms. We thus evaluated seizure susceptibility and hippocampal network hyperexcitability at ~3 weeks of age [prior to amyloid beta (Abeta) plaque deposition, neurofibrillary pathology, and cognitive impairment] in a triple transgenic mouse model of familial AD (3xTg-AD mouse) that harbors mutated human Abeta precursor protein (APP), tau and presenilin 1 (PS1) genes. Audiogenic seizures were elicited in a higher proportion of 3xTg-AD mice compared with wild type (WT) controls. Seizure susceptibility in 3xTg-AD mice was attenuated either by passive immunization with anti-human APP/Abeta antibody (6E10) or by blockade of metabotropic glutamate receptor 5 (mGluR5) with the selective antagonist, 2-methyl-6-(phenylethynyl)pyridine hydrochloride (MPEP). In in vitro hippocampal slices, suppression of synaptic inhibition with the GABAA receptor antagonist, bicuculline, induced prolonged epileptiform (>1.5 s in duration) ictal-like discharges in the CA3 neuronal network in the majority of the slices from 3xTg-AD mice. In contrast, only short epileptiform (<1.5 s in duration) interictal-like discharges were observed following bicuculline application in the CA3 region of WT slices. The ictal-like activity in CA3 region of the hippocampus was significantly reduced in the 6E10-immunized compared to the saline-treated 3xTg-AD mice. MPEP acutely suppressed the ictal-like discharges in 3xTg-AD slices. Remarkably, epileptiform discharge duration positively correlated with intraneuronal human (transgenic) APP/Abeta expression in the CA3 region of the hippocampus. Our data suggest that in a mouse model of familial AD, hypersynchronous network activity underlying seizure susceptibility precedes Abeta plaque pathology and memory impairment. This early-onset network hyperexcitability can be suppressed by passive immunization with an anti-human APP/Abeta antibody and by mGluR5 blockade in 3xTg-AD mice.
28392767	20	37	Hyperexcitability	Disease	
28392767	56	75	Alzheimer's Disease	Disease	MESH:D000544
28392767	87	91	Mice	Species	10090
28392767	140	145	Human	Species	9606
28392767	150	155	Abeta	Gene	11820
28392767	172	178	mGluR5	Gene	108071
28392767	222	239	hyperexcitability	Disease	
28392767	272	291	Alzheimer's disease	Disease	MESH:D000544
28392767	293	295	AD	Disease	MESH:D000544
28392767	333	350	memory impairment	Disease	MESH:D008569
28392767	382	399	hyperexcitability	Disease	
28392767	409	426	memory impairment	Disease	MESH:D008569
28392767	430	435	mouse	Species	10090
28392767	446	448	AD	Disease	MESH:D000544
28392767	516	523	seizure	Disease	MESH:D012640
28392767	563	580	hyperexcitability	Disease	
28392767	610	622	amyloid beta	Gene	351
28392767	624	629	Abeta	Gene	351
28392767	681	701	cognitive impairment	Disease	MESH:D003072
28392767	726	731	mouse	Species	10090
28392767	741	752	familial AD	Disease	MESH:D000544
28392767	759	761	AD	Disease	MESH:D000544
28392767	762	767	mouse	Species	10090
28392767	790	795	human	Species	9606
28392767	827	830	tau	Gene	4137
28392767	835	847	presenilin 1	Gene	19164
28392767	849	852	PS1	Gene	19164
28392767	861	880	Audiogenic seizures	Disease	MESH:D020195
28392767	926	928	AD	Disease	MESH:D000544
28392767	929	933	mice	Species	10090
28392767	973	980	Seizure	Disease	MESH:D012640
28392767	1004	1006	AD	Disease	MESH:D000544
28392767	1007	1011	mice	Species	10090
28392767	1068	1073	human	Species	9606
28392767	1078	1083	Abeta	Gene	351
28392767	1094	1098	6E10	Chemical	-
28392767	1118	1151	metabotropic glutamate receptor 5	Gene	108071
28392767	1153	1159	mGluR5	Gene	108071
28392767	1192	1240	2-methyl-6-(phenylethynyl)pyridine hydrochloride	Chemical	-
28392767	1242	1246	MPEP	Chemical	-
28392767	1352	1363	bicuculline	Chemical	MESH:D001640
28392767	1383	1395	epileptiform	Disease	MESH:D014277
28392767	1507	1509	AD	Disease	MESH:D000544
28392767	1510	1514	mice	Species	10090
28392767	1540	1552	epileptiform	Disease	MESH:D014277
28392767	1625	1636	bicuculline	Chemical	MESH:D001640
28392767	1822	1824	AD	Disease	MESH:D000544
28392767	1825	1829	mice	Species	10090
28392767	1831	1835	MPEP	Chemical	-
28392767	1888	1891	-AD	CellLine	CVCL:RN76
28392767	1912	1934	epileptiform discharge	Disease	MESH:D019522
28392767	1985	1990	human	Species	9606
28392767	2008	2013	Abeta	Gene	11820
28392767	2090	2095	mouse	Species	10090
28392767	2105	2116	familial AD	Disease	MESH:D000544
28392767	2163	2170	seizure	Disease	MESH:D012640
28392767	2195	2200	Abeta	Gene	11820
28392767	2222	2239	memory impairment	Disease	MESH:D008569
28392767	2266	2283	hyperexcitability	Disease	
28392767	2339	2344	human	Species	9606
28392767	2349	2354	Abeta	Gene	11820
28392767	2371	2377	mGluR5	Gene	108071
28392767	2390	2395	3xTg-	CellLine	CVCL:C6V6
28392767	2395	2397	AD	Disease	MESH:D000544
28392767	2398	2402	mice	Species	10090
28392767	Association	MESH:D000544	108071
28392767	Positive_Correlation	MESH:D001640	MESH:D014277
28392767	Association	MESH:D000544	4137
28392767	Association	MESH:D019522	11820
28392767	Association	MESH:D012640	108071
28392767	Association	MESH:D000544	19164

